Skip to main navigation Skip to search Skip to main content

KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation

  • César Serrano
  • , Yuexiang Wang
  • , Adrián Mariño-Enríquez
  • , Jen Chieh Lee
  • , Gloria Ravegnini
  • , Jeffrey A. Morgan
  • , Monica M. Bertagnolli
  • , Carol Beadling
  • , George D. Demetri
  • , Christopher L. Corless
  • , Michael C. Heinrich
  • , Jonathan A. Fletcher

Research output: Contribution to journal › Article › peer-review

51   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation'. Together they form a unique fingerprint.
Sort by